Sk. Srivastava et al., MECHANISM OF DIFFERENTIAL EFFICACY OF GARLIC ORGANOSULFIDES IN PREVENTING BENZO(A)PYRENE-INDUCED CANCER IN MICE, Cancer letters, 118(1), 1997, pp. 61-67
The mechanism of differential efficacies of diallyl sulfide (DAS), dia
llyl disulfide (DADS), diallyl trisulfide (DATS), dipropyl sulfide (DP
S) and dipropyl disulfide (DPDS) in preventing benzo(a)pyrene (BP)-ind
uced cancer in mice has been investigated by determining their effects
on the enzymes of BP activation/inactivation pathways. With the excep
tion of DATS, treatment of mice with other organosulfides (OSCs) cause
d a small but significant increase (37-44%) in hepatic ethoxyresorufin
O-deethylase (EROD) activity. However, the forestomach EROD activity
did not differ significantly between control and treated groups. Only
DAS treatment caused a modest but statistically significant reduction
(about 25%) in pulmonary EROD activity. These results suggest that whi
le reduction of EROD activity may, at least in part, contribute to the
DAS-mediated inhibition of BP-induced lung cancer, anticarcinogenic e
ffects of OSCs against BP-induced forestomach carcinogenesis seems to
be independent of this mechanism. Treatment of mice with DAS, DADS and
DATS resulted in a significant increase, as compared with control, in
both hepatic (3.0-, 3.2- and 4.4-fold, respectively) and forestomach
(1.5-, 2.7- and 2.7-fold, respectively) glutathione transferase (GST)
activity toward anti-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-oxy-7,8
,9,10-tetrahydrobenzo(a)pyrene (anti-BPDE), which is the ultimate carc
inogen of BP. The pulmonary GST activity was not increased by any of t
he OSCs. Even though epoxide hydrolase (EH) activity was differentiall
y altered by these OSCs, a correlation between chemopreventive efficac
y of OSCs and their effects on EH activity was not apparent. The resul
ts of the present study suggest that differences in the ability of OSC
s to modulate GST activity toward anti-BPDE may, at least in part, acc
ount for their differential chemopreventive efficacy against BP-induce
d cancer in mice. (C) 1997 Elsevier Science Ireland Ltd.